PSA screening - a review of recent studies

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 402-404

  Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SENSITIVITY AND SPECIFICITY;

AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70349104584     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70065-6     Document Type: Article

References (7)

1. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 17 (1991) 1156-1161
2. Schröder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328
3. Globocan 2002. www.iarc.fr
4. Thompson I.M., Chi C., Ankerst D.P., et al. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst 98 16 (2006) 1128-1133
5. Andriole G.L., Crawford E.D., Grubb III R.L., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360 13 (2009 Mar 26) 1310-1319 [Epub 2009 Mar 18].
6. Grubb III R.L., Pinsky P.F., Greenlee R.T., et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: an update on findings from the initial four rounds of screening in a randomized trial. BJU Int 102 11 (2008) 1524-1530
7. Steyerberg E.W., Roobol M.J., Kattan M.W., van der Kwast T.H., de Koning H.J., and Schröder F.H. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 177 1 (2007) 107-112 discussion 112.